Inventor · disambiguated record
Nicholas D. Smith
Also filed as: SMITH NICHOLAS · SMITH NICHOLAS D · SMITH NICHOLAS DAVID
61 granted patents·43 pending applications·682 citations·filing 1987–2024
99Inventor score
Top patents by PatentIndex Score
104 records- 0197US8853423B2Indane estrogen receptor modulators and uses thereofGOVEK STEVEN P·Filed 2011·Granted Oct 7, 2014·53 cites·11 claims
- 0297US8455534B2Estrogen receptor modulators and uses thereofSMITH NICHOLAS D·Filed 2012·Granted Jun 4, 2013·66 cites·18 claims
- 0397US8299112B2Estrogen receptor modulators and uses thereofSMITH NICHOLAS D·Filed 2011·Granted Oct 30, 2012·72 cites·12 claims
- 0496US9475798B2Azetidine estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2015·Granted Oct 25, 2016·20 cites·14 claims
- 0596US9078871B2Estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2013·Granted Jul 14, 2015·50 cites·22 claims
- 0696US8703810B2Estrogen receptor modulators and uses thereofKAHRAMAN MEHMET·Filed 2011·Granted Apr 22, 2014·65 cites·21 claims
- 0794US9340524B2Androgen receptor modulator and uses thereofARAGON PHARMACEUTICALS INC·Filed 2014·Granted May 17, 2016·25 cites·4 claims
- 0892US9845291B2Estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2015·Granted Dec 19, 2017·15 cites·14 claims
- 0991US10626081B2Farnesoid X receptor agonists and uses thereofMETACRINE INC·Filed 2016·Granted Apr 21, 2020·4 cites·18 claims
- 1091US9873684B2Estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2015·Granted Jan 23, 2018·11 cites·16 claims
- 1191US9655880B2Azetidine estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2016·Granted May 23, 2017·5 cites·18 claims
- 1291US9193714B2Fluorinated estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2012·Granted Nov 24, 2015·18 cites·14 claims
- 1390US9108944B2Androgen receptor modulators and uses thereofSMITH NICHOLAS D·Filed 2011·Granted Aug 18, 2015·16 cites·38 claims
- 1489US10377717B2Farnesoid X receptor agonists and uses thereofMETACRINE INC·Filed 2016·Granted Aug 13, 2019·3 cites·18 claims
- 1589US9481664B2Androgen receptor modulators and uses thereofARAGON PHARMACEUTICALS INC·Filed 2015·Granted Nov 1, 2016·8 cites·42 claims
- 1689US2025092011A1Crystalline Forms Of An Androgen Receptor ModulatorARAGON PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1788US9187460B2Estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2012·Granted Nov 17, 2015·11 cites·17 claims
- 1887US11773094B2Farnesoid X receptor agonists and uses thereofMETACRINE INC·Filed 2021·Granted Oct 3, 2023·1 cites·19 claims
- 1987US10927082B2Farnesoid X receptor agonists and uses thereofMETACRINE INC·Filed 2020·Granted Feb 23, 2021·2 cites·2 claims
- 2087US9855270B2Methods and compositions for modulating estrogen receptor mutantsGENENTECH INC·Filed 2015·Granted Jan 2, 2018·4 cites·35 claims
- 2187US8394005B2Exercise tableSOLOW HOWARD JAY·Filed 2009·Granted Mar 12, 2013·43 cites·18 claims
- 2286US10961198B2Farnesoid X receptor agonists and uses thereofMETACRINE INC·Filed 2018·Granted Mar 30, 2021·2 cites·4 claims
- 2386US8609852B2Thiazolyl mGluR5 antagonists and methods for their useCOSFORD NICHOLAS D·Filed 2012·Granted Dec 17, 2013·12 cites·2 claims
- 2486US7462619B2Pyridazine, pyrimidine and pyrazine ethyne compoundsMERCK & CO INC·Filed 2005·Granted Dec 9, 2008·5 cites·2 claims
- 2585US10934271B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2020·Granted Mar 2, 2021·1 cites·17 claims
- 2685US9481663B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2013·Granted Nov 1, 2016·5 cites·21 claims
- 2785US8360943B2Balance boardSMITH NICHOLAS DAVID·Filed 2011·Granted Jan 29, 2013·16 cites·17 claims
- 2885US2025289821A1Farnesoid x receptor agonists and uses thereofLILLY CO ELI·Filed 2024·Application pending·0 cites
- 2984US11084817B2Farnesoid X receptor agonists and uses thereofMETACRINE INC·Filed 2019·Granted Aug 10, 2021·3 cites·15 claims
- 3084US10308630B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2018·Granted Jun 4, 2019·2 cites·9 claims
- 3184US8062199B2Balance boardSMITH NICHOLAS DAVID·Filed 2007·Granted Nov 22, 2011·21 cites·5 claims
- 3283US10703712B2Farnesoid X receptor agonists and uses thereofMETACRINE INC·Filed 2016·Granted Jul 7, 2020·2 cites·16 claims
- 3383US9586952B2Polycyclic estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2014·Granted Mar 7, 2017·7 cites·37 claims
- 3483US9399646B2Estrogen receptor modulators and uses thereofSMITH NICHOLAS D·Filed 2011·Granted Jul 26, 2016·6 cites·15 claims
- 3582US11236071B1Farnesoid X receptor agonists and uses thereofMETACRINE INC·Filed 2018·Granted Feb 1, 2022·2 cites·18 claims
- 3682US7879882B2Thiazolyl mglur5 antagonists and methods for their useMERCK SHARP & DOHME·Filed 2005·Granted Feb 1, 2011·4 cites·2 claims
- 3781US7105548B2Heteroaryl substituted triazole modulators of metabotropic glutamate receptor-5MERCK & CO INC·Filed 2002·Granted Sep 12, 2006·15 cites·6 claims
- 3880US7253190B2Heteroaryl substituted tetrazole modulators of metabotrophic glutamate receptor-5MERCK & CO INC·Filed 2002·Granted Aug 7, 2007·14 cites·6 claims
- 3980US2023382913A1Farnesoid x receptor agonists and uses thereofORGANOVO INC·Filed 2023·Application pending·0 cites
- 4078US10766875B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2019·Granted Sep 8, 2020·0 cites·19 claims
- 4178US9617602B2Methods and compositions for determining resistance to androgen receptor therapyARAGON PHARMACEUTICALS INC·Filed 2013·Granted Apr 11, 2017·6 cites·31 claims
- 4278US9499538B2Estrogen receptor modulators and uses thereofSERAGON PHARMACEUTICALS INC·Filed 2013·Granted Nov 22, 2016·4 cites·13 claims
- 4377US12018008B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2021·Granted Jun 25, 2024·0 cites·41 claims
- 4477US10053451B2Heterocyclic estrogen receptor modulators and uses thereofGENENTECH INC·Filed 2016·Granted Aug 21, 2018·2 cites·10 claims
- 4577US9994545B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2016·Granted Jun 12, 2018·1 cites·21 claims
- 4674US2025057997A1Conjugates comprising covalent binders for targeting intracellular proteinsRAYZEBIO INC·Filed 2024·Application pending·0 cites
- 4774US2024342318A1Conjugates comprising covalent binders for targeting intracellular proteinsRAYZEBIO INC·Filed 2024·Application pending·0 cites
- 4873US7514409B2VLA-4 antagonistsMERCK & CO INC·Filed 2005·Granted Apr 7, 2009·2 cites·9 claims
- 4973US7365074B2Pyridazine, pyrimidine and pyrazine ethyne compoundsMERCK & CO INC·Filed 2004·Granted Apr 29, 2008·5 cites·2 claims
- 5072US10556882B2Crystalline forms of an androgen receptor modulatorARAGON PHARMACEUTICALS INC·Filed 2019·Granted Feb 11, 2020·0 cites·19 claims
Showing the top 50 of 104 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Nicholas D. Smith files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →